
Data partnerships help coordinate HIV and opioid use disorder (OUD) services across state programs. These relationships can help state agencies identify service overlap and gaps, identify common goals, and initiate collaboration.
Data partnerships help coordinate HIV and opioid use disorder (OUD) services across state programs. These relationships can help state agencies identify service overlap and gaps, identify common goals, and initiate collaboration.
State health departments must dedicate staff and time to ensure a consistent approach to HIV and opioid use disorder (OUD) service delivery. For some states, this means creating new staff roles.
This resource describes how state health departments and other public health organizations can partner with people with HIV and/or who use(d) drugs in programmatic and policy making processes and evaluation.
Language is foundational to how we understand and interact with ourselves and others. Unclear language can lead to confusion and inefficiencies, while stigmatizing and prejudicial language leads to harmful practices and dehumanizes people.
Articles in this supplement focus on the global opioid crisis, including coverage of harm reduction approaches, health justice promotion, and lessons learned.
This publication describes the recent trends of drug overdose deaths in the United States (U.S.) and the benefits of adopting harm reduction approaches.
The COVID-19 pandemic resulted in federal policy changes related to telehealth use that allowed states to maximize access to medications for opioid use disorder (MOUD) through telehealth.
Individuals who have HIV who also use drugs experience increased age-matched morbidity and mortality in comparison with those with HIV who do not use drugs.
This PowerPoint slide deck reviews the foundations of harm reduction philosophy and practice, summarizes drug user health issues and trends, and aims to increase cultural competence and humility when working with people who use drugs.
This CDC report provides updated data related to HIV prevalence among people who inject drugs, documenting findings that underscore the need for low-barrier access to comprehensive and integrated needs-based syringe service programs for necessary prevention and